Expanding spectrum of anticancer drug, imatinib, in the disorders affecting brain and spinal cord

[Display omitted] Imatinib is a tyrosine kinase inhibitor and is used as a first line drug in the treatment of Philadelphia-chromosome-positive chronic myeloid leukaemia and gastrointestinal stromal tumors. Being tyrosine kinase inhibitor, imatinib modulates the activities of Abelson gene (c-Abl), A...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Pharmacological research Ročník 143; s. 86 - 96
Hlavní autori: Kumar, Manish, Kulshrestha, Ritu, Singh, Nirmal, Jaggi, Amteshwar Singh
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Netherlands Elsevier Ltd 01.05.2019
Predmet:
Alzheimer’s disease
Animals
Antineoplastic Agents - pharmacology
Antineoplastic Agents - therapeutic use
Brain
Humans
Imatinib
Imatinib Mesylate - pharmacology
Imatinib Mesylate - therapeutic use
Multiple sclerosis
Nervous System Diseases - drug therapy
Nervous System Diseases - metabolism
Parkinson disease
Protein Kinase Inhibitors - pharmacology
Protein Kinase Inhibitors - therapeutic use
Spinal Cord
Spinal cord injury
Stroke
Tyrosine kinase
NF-κβ
Multiple sclerosis
BBB
FLT3
Parkinson disease
Spinal cord injury
LPS
Aβ
Tyrosine kinase
AICD
PDGFR
t-PA
Imatinib
Stroke
AD
MOG
Alzheimer’s disease
c-kit
EAE
c-Abl
MAPK
IL-6
MMP
β-CTF
APC
TNF-α
Lck
ARG
AβPP
GSAP
MPTP
HEK cells
ISSN:1043-6618, 1096-1186, 1096-1186
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract [Display omitted] Imatinib is a tyrosine kinase inhibitor and is used as a first line drug in the treatment of Philadelphia-chromosome-positive chronic myeloid leukaemia and gastrointestinal stromal tumors. Being tyrosine kinase inhibitor, imatinib modulates the activities of Abelson gene (c-Abl), Abelson related gene (ARG), platelet-derived growth factor receptor (PDGFR), FMS-like tyrosine kinase 3 (FLT3), lymphocyte-specific protein (Lck), mitogen activated protein kinase (MAPK), amyloid precursor protein intracellular domain (AICD), α-synuclein and the stem-cell factor receptor (c-kit). Studies have shown the role of imatinib in modulating the pathophysiological state of a number of disorders affecting brain and spinal cord such as Alzheimer’s disease, Parkinson’s disease, stroke, multiple sclerosis and spinal cord injury. The present review discusses the role of imatinib in the above described disorders and the possible mechanisms involved in these diseases.
AbstractList Imatinib is a tyrosine kinase inhibitor and is used as a first line drug in the treatment of Philadelphia-chromosome-positive chronic myeloid leukaemia and gastrointestinal stromal tumors. Being tyrosine kinase inhibitor, imatinib modulates the activities of Abelson gene (c-Abl), Abelson related gene (ARG), platelet-derived growth factor receptor (PDGFR), FMS-like tyrosine kinase 3 (FLT3), lymphocyte-specific protein (Lck), mitogen activated protein kinase (MAPK), amyloid precursor protein intracellular domain (AICD), α-synuclein and the stem-cell factor receptor (c-kit). Studies have shown the role of imatinib in modulating the pathophysiological state of a number of disorders affecting brain and spinal cord such as Alzheimer's disease, Parkinson's disease, stroke, multiple sclerosis and spinal cord injury. The present review discusses the role of imatinib in the above described disorders and the possible mechanisms involved in these diseases.Imatinib is a tyrosine kinase inhibitor and is used as a first line drug in the treatment of Philadelphia-chromosome-positive chronic myeloid leukaemia and gastrointestinal stromal tumors. Being tyrosine kinase inhibitor, imatinib modulates the activities of Abelson gene (c-Abl), Abelson related gene (ARG), platelet-derived growth factor receptor (PDGFR), FMS-like tyrosine kinase 3 (FLT3), lymphocyte-specific protein (Lck), mitogen activated protein kinase (MAPK), amyloid precursor protein intracellular domain (AICD), α-synuclein and the stem-cell factor receptor (c-kit). Studies have shown the role of imatinib in modulating the pathophysiological state of a number of disorders affecting brain and spinal cord such as Alzheimer's disease, Parkinson's disease, stroke, multiple sclerosis and spinal cord injury. The present review discusses the role of imatinib in the above described disorders and the possible mechanisms involved in these diseases.
Imatinib is a tyrosine kinase inhibitor and is used as a first line drug in the treatment of Philadelphia-chromosome-positive chronic myeloid leukaemia and gastrointestinal stromal tumors. Being tyrosine kinase inhibitor, imatinib modulates the activities of Abelson gene (c-Abl), Abelson related gene (ARG), platelet-derived growth factor receptor (PDGFR), FMS-like tyrosine kinase 3 (FLT3), lymphocyte-specific protein (Lck), mitogen activated protein kinase (MAPK), amyloid precursor protein intracellular domain (AICD), α-synuclein and the stem-cell factor receptor (c-kit). Studies have shown the role of imatinib in modulating the pathophysiological state of a number of disorders affecting brain and spinal cord such as Alzheimer's disease, Parkinson's disease, stroke, multiple sclerosis and spinal cord injury. The present review discusses the role of imatinib in the above described disorders and the possible mechanisms involved in these diseases.
[Display omitted] Imatinib is a tyrosine kinase inhibitor and is used as a first line drug in the treatment of Philadelphia-chromosome-positive chronic myeloid leukaemia and gastrointestinal stromal tumors. Being tyrosine kinase inhibitor, imatinib modulates the activities of Abelson gene (c-Abl), Abelson related gene (ARG), platelet-derived growth factor receptor (PDGFR), FMS-like tyrosine kinase 3 (FLT3), lymphocyte-specific protein (Lck), mitogen activated protein kinase (MAPK), amyloid precursor protein intracellular domain (AICD), α-synuclein and the stem-cell factor receptor (c-kit). Studies have shown the role of imatinib in modulating the pathophysiological state of a number of disorders affecting brain and spinal cord such as Alzheimer’s disease, Parkinson’s disease, stroke, multiple sclerosis and spinal cord injury. The present review discusses the role of imatinib in the above described disorders and the possible mechanisms involved in these diseases.
Author Jaggi, Amteshwar Singh
Singh, Nirmal
Kumar, Manish
Kulshrestha, Ritu
Author_xml – sequence: 1
  givenname: Manish
  surname: Kumar
  fullname: Kumar, Manish
  organization: Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Punjab, 147002, India
– sequence: 2
  givenname: Ritu
  surname: Kulshrestha
  fullname: Kulshrestha, Ritu
  organization: Vallabhbhai Patel Chest Institute, New Delhi, 110007, India
– sequence: 3
  givenname: Nirmal
  surname: Singh
  fullname: Singh, Nirmal
  organization: Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Punjab, 147002, India
– sequence: 4
  givenname: Amteshwar Singh
  surname: Jaggi
  fullname: Jaggi, Amteshwar Singh
  email: amteshwarjaggi@gmail.com
  organization: Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Punjab, 147002, India
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30902661$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtv1TAQhS1URB_wB1ggL1mQ4IkTJ5bYoKo8pEpsYG059rj1Va4T7ATRf89Et92w6GpGmu8cac65ZGdpTsjYWxA1CFAfD_Vyn0vdCNC1kLWA9gW7AKFVBTCos31vZaUUDOfsspSDEEK3IF6xcym0aOhwwezN38UmH9MdLwu6NW9HPgdu0xqdTQ4z93m7-8Dj0a4xxZG2xNd75D6WOXvMhdsQSLg7jNnSlezIKyY7cUfIa_Yy2Kngm8d5xX59ufl5_a26_fH1-_Xn28q1QqyV8y0O2gYEhLELvW97GaxVI-pu6AkRqLSVupHQ9_3og-q9dA660MAwOC2v2PuT75Ln3xuW1RxjcThNNuG8FdOAVp2ErlGEvntEt_GI3iyZ3ssP5ikWAoYT4PJcSsZgXFwpgDmt9OJkQJi9AXMwewNmb8AIaagBkjb_SZ_cnxV9OomQAvoTMZviIlL8PmbK1vg5Pif_BwfRn84
CitedBy_id crossref_primary_10_1186_s12987_021_00255_2
crossref_primary_10_3389_fnins_2023_1259622
crossref_primary_10_4103_1673_5374_375304
crossref_primary_10_3390_cells10030593
crossref_primary_10_1155_2022_9233749
crossref_primary_10_3390_ijms22031059
crossref_primary_10_3390_ph13090242
crossref_primary_10_1371_journal_pcbi_1011809
crossref_primary_10_1038_s41598_020_57676_6
crossref_primary_10_1097_FJC_0000000000001344
crossref_primary_10_1016_j_biopha_2023_115778
crossref_primary_10_1186_s12967_025_06739_1
crossref_primary_10_3390_brainsci10110858
crossref_primary_10_2174_0125899775327220240822111611
crossref_primary_10_1002_2211_5463_13969
crossref_primary_10_1007_s12035_024_04431_x
crossref_primary_10_3390_ijms22084137
crossref_primary_10_4103_ijp_ijp_726_23
crossref_primary_10_1016_j_wneu_2024_123648
crossref_primary_10_1080_14656566_2021_1918674
crossref_primary_10_1038_s41598_025_88134_w
crossref_primary_10_1089_neu_2020_7413
crossref_primary_10_1021_acs_cgd_4c00926
crossref_primary_10_1134_S1068162022020066
crossref_primary_10_3390_ijms25031751
crossref_primary_10_1002_jnr_24715
crossref_primary_10_1007_s11064_022_03758_y
crossref_primary_10_1007_s00210_020_01862_w
crossref_primary_10_1155_2023_9598783
crossref_primary_10_1007_s43152_021_00032_1
crossref_primary_10_1080_07391102_2023_2262586
crossref_primary_10_1186_s43094_025_00801_x
Cites_doi 10.1056/NEJMra013339
10.1038/sj.cr.7290257
10.1371/journal.pone.0024831
10.1093/brain/awh655
10.1186/1750-1326-9-48
10.1007/s10875-011-9579-6
10.1002/msj.20279
10.1042/BJ20100323
10.14336/AD.2016.1120
10.1016/j.bbi.2013.05.002
10.1371/journal.pone.0038760
10.1073/pnas.1534745100
10.1523/JNEUROSCI.2868-05.2005
10.1016/j.neuron.2005.04.008
10.1002/ana.22549
10.1371/journal.pone.0056586
10.1038/ng0492-45
10.1056/NEJM200104053441401
10.1186/1750-1326-5-58
10.1016/j.molbrainres.2005.01.012
10.1046/j.1365-2141.2002.03881.x
10.1182/blood-2002-10-3059
10.1007/s11481-018-9783-8
10.1091/mbc.e07-01-0035
10.1126/science.1058783
10.3233/JAD-140105
10.1007/s12291-013-0387-z
10.1074/jbc.M112.370924
10.1074/jbc.M207825200
10.1002/jcp.23029
10.1007/s12975-014-0333-2
10.1038/nm1787
10.1016/j.brainres.2014.03.027
10.3233/JAD-151087
10.1016/j.ajpath.2010.11.012
10.1042/BJ20040927
10.1002/jnr.23475
10.1016/j.bbr.2012.01.010
10.1172/JCI29178
10.1074/jbc.271.39.23775
10.1007/978-3-642-01222-8_1
10.3233/JAD-2011-110746
10.1017/S1462399409001148
10.1097/BSD.0000000000000287
10.7150/ijms.1.101
10.1182/blood-2006-02-005686
10.1172/JCI11830
10.3233/JAD-2000-23-408
10.1136/ewjm.173.3.209
10.1016/S0140-6736(09)60371-8
10.1523/JNEUROSCI.4511-08.2008
10.1016/j.neuroscience.2016.06.007
10.12659/MSM.900218
10.1002/jnr.22603
10.1111/j.1742-4658.2012.08491.x
10.1007/s00401-017-1755-1
10.1016/j.neurobiolaging.2009.07.007
10.1111/joim.12576
10.1016/S0896-6273(03)00434-3
10.1016/j.nbd.2012.01.005
10.1038/nature09325
10.1159/000343302
10.1186/s40478-018-0634-x
10.3748/wjg.v21.i11.3174
10.1046/j.1471-4159.2002.00855.x
10.1111/j.1471-4159.1988.tb03029.x
10.1007/s00401-017-1749-z
10.1038/cdd.2015.135
10.1517/14740338.2016.1152258
10.1007/s12026-015-8624-6
10.1073/pnas.1620963114
10.1212/CON.0000000000000307
10.1002/ijc.23063
10.1007/978-94-007-5416-4_14
10.1016/j.nbd.2004.06.007
10.1093/brain/awn125
10.1016/j.neuint.2013.05.006
10.33549/physiolres.933480
10.1074/jbc.M513903200
10.1007/s12975-014-0358-6
10.1186/1742-2094-5-37
10.1016/j.brainres.2009.08.076
ContentType Journal Article
Copyright 2019 Elsevier Ltd
Copyright © 2019 Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2019 Elsevier Ltd
– notice: Copyright © 2019 Elsevier Ltd. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.phrs.2019.03.014
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1096-1186
EndPage 96
ExternalDocumentID 30902661
10_1016_j_phrs_2019_03_014
S1043661818321054
Genre Journal Article
Review
GroupedDBID ---
--K
--M
.GJ
.~1
0R~
0SF
0ZK
123
1B1
1RT
1~.
1~5
29O
3O-
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATCM
AAXUO
ABFNM
ABFRF
ABJNI
ABMAC
ABOCM
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACRLP
ADBBV
ADEZE
ADFGL
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
C45
CAG
COF
CS3
DM4
DU5
EBS
EFBJH
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
GROUPED_DOAJ
HMT
HVGLF
HX~
HZ~
IHE
J1W
KOM
L7B
LG5
M33
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SPT
SSP
SSZ
T5K
TEORI
UNMZH
WUQ
XPP
ZA5
ZU3
ZXP
~G-
9DU
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACLOT
ACRPL
ACVFH
ADCNI
ADNMO
ADVLN
AEIPS
AEUPX
AFJKZ
AFPUW
AGQPQ
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
CITATION
EFKBS
~HD
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c400t-cd4e89afe1e1b5f7d473faa6be95874000e69a39231777bdf67d3cc15f2188c93
ISICitedReferencesCount 35
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000466827800009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1043-6618
1096-1186
IngestDate Thu Oct 02 03:57:29 EDT 2025
Wed Feb 19 02:30:33 EST 2025
Sat Nov 29 07:05:43 EST 2025
Tue Nov 18 21:20:24 EST 2025
Fri Feb 23 02:19:15 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords NF-κβ
Multiple sclerosis
BBB
FLT3
Parkinson disease
Spinal cord injury
LPS
Aβ
Tyrosine kinase
AICD
PDGFR
t-PA
Imatinib
Stroke
AD
MOG
Alzheimer’s disease
c-kit
EAE
c-Abl
MAPK
IL-6
MMP
β-CTF
APC
TNF-α
Lck
ARG
AβPP
GSAP
MPTP
HEK cells
Language English
License Copyright © 2019 Elsevier Ltd. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c400t-cd4e89afe1e1b5f7d473faa6be95874000e69a39231777bdf67d3cc15f2188c93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://doi.org/10.1016/j.phrs.2019.03.014
PMID 30902661
PQID 2196531526
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_2196531526
pubmed_primary_30902661
crossref_citationtrail_10_1016_j_phrs_2019_03_014
crossref_primary_10_1016_j_phrs_2019_03_014
elsevier_sciencedirect_doi_10_1016_j_phrs_2019_03_014
PublicationCentury 2000
PublicationDate May 2019
2019-05-00
20190501
PublicationDateYYYYMMDD 2019-05-01
PublicationDate_xml – month: 05
  year: 2019
  text: May 2019
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Pharmacological research
PublicationTitleAlternate Pharmacol Res
PublicationYear 2019
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Adzemovic, Zeitelhofer, Eriksson, Olsson, Nilsson (bib0065) 2013; 8
Shiba, Suzuki, Fujimoto, Shimojo, Imanaka-Yoshida, Yoshida, Kanamaru, Matsushima, Taki (bib0340) 2012; 46
Galan-Moya, Hernandez-Losa, Aceves Luquero, de la Cruz-Morcillo, Ramírez-Castillejo, Callejas-Valera, Arriaga, Aranburo, Ramón y Cajal, Silvio Gutkind, Sánchez-Prieto (bib0420) 2008; 122
Bengoa-Vergniory, Roberts, Wade-Martins, Alegre-Abarrategui (bib0450) 2017; 134
Joice, Mydeen, Couraud, Weksler, Romero, Fraser, Easton (bib0295) 2009; 17
Qureshi, Mendelow, Hanley (bib0325) 2009; 373
Liu, Song, Zhu (bib0405) 2017; 2
Kahn, Kranjac, Alonzo, Haase, Cedillos, McLinden, Boehm, Chumley (bib0120) 2012; 229
Zhan, Krafft, Lekic, Ma, Souvenir, Zhang, Tang (bib0060) 2015; 93
Baccarani, Saglio, Goldman, Hochhaus, Simonsson, Appelbaum, Apperley, Cervantes, Cortes, Deininger, Gratwohl, Guilhot, Horowitz, Hughes, Kantarjian, Larson, Niederwieser, Silver, Hehlmann (bib0005) 2006; 108
Jacobsen, Scherer, Mouritsen, Bragadóttir, Thomas Bäckström, Sardar, Holmberg, Koleske, Andersson (bib0370) 2018; 13
Oddo, Caccamo, Shepherd, Murphy, Golde, Kayed, Metherate, Mattson, Akbari, LaFerla (bib0160) 2003; 39
Gardner, White, Eimerbrink, Boehm, Chumley (bib0115) 2016; 7
Cancino, Perez de Arce, Castro, Toledo, von Bernhardi, Alvarez (bib0075) 2011; 32
Apostolova (bib0100) 2016; 22
Estrada, Chamorro, Yañez, Gonzalez, Leal, von Bernhardi, Dulcey, Marugan, Ferrer, Soto, Zanlungo, Inestrosa, Alvarez (bib0155) 2016; 54
Wu, Chen, Li, Wang, Diao, Liu (bib0045) 2014; 7
He, Luo, Li, Remmers, Netzer, Hendrick, Bettayeb, Flajolet, Gorelick, Wennogle, Greengard (bib0165) 2010; 467
Sutcliffe, Hedlund, Thomas, Bloom, Hilbush (bib0145) 2011; 89
Qi, Shang, Liao, Su, Jing, Wu, Bi, Jia (bib0195) 2018
Netzer, Bettayeb, Sinha, Flajolet, Greengard, Bustos (bib0210) 2017; 114
Parmar, Sumaria, Hashi (bib0265) 2011; 3
Merali, Leung, Mikulis, Silver, Kassner (bib0270) 2015; 6
Freeman, Niego, Croucher, Pedersen, Medcalf (bib0310) 2014; 27
Mahad, Callahan, Williams, Ubogu, Kivisäkk, Tucky, Kidd, Kingsbury, Chang, Fox, Mack, Sniderman, Ravid, Staugaitis, Stins, Ransohoff (bib0360) 2006; 129
Wu, Chen, Ma, He, Huang, Liu, Li, Yuan (bib0070) 2016; 23
Witiw, Fehlings (bib0465) 2015; 28
Savage, Antman (bib0015) 2002; 346
Wu, Wang, Gu, Ge, Liang, Qin (bib0445) 2013; 63
Alves Da Costa, Paitel, Vincent, Checler (bib0455) 2002; 277
Chu, Lauretti, Craige, Praticò (bib0170) 2014; 41
Azizi, Haidari, Khorramizadeh, Naddafi, Sadria, Javanbakht, Sedaghat, Zavareh, Mirshafiey (bib0355) 2014; 13
El-Deiry, Kern, Pietenpol, Kinzler, Vogelstein (bib0430) 1992; 1
Druker, Talpaz, Resta, Peng, Buchdunger, Ford, Lydon, Kantarjian, Capdeville, Ohno-Jones, Sawyers (bib0025) 2001; 344
Tak, Firestein (bib0285) 2001; 107
Wahlgren, Thorén, Höjeberg, Käll, Laska, Sjöstrand, Höijer, Almqvist, Holmin, Lilja, Fredriksson (bib0305) 2017; 281
Ma, Huang, Khatibi, Rolland, Suzuki, Zhang, Tang (bib0055) 2011; 70
Kegel, Sapp, Alexander, Reeves, Bleckmann, Sobin, Masso, Valencia, Jeong, Krainc, Palacino, Curtis, Kuhn, Betschart, Sena-Esteves, Aronin, Paganetti, Difiglia (bib0080) 2010; 14
Julien, Tomberlin, Roberts, Akram, Stein, Silverman, Link (bib0190) 2018; 6
Hsuchou, Kastin, Mishra, Pan (bib0300) 2012; 30
Alvarez, Sandoval, Leal, Castro, Kosik (bib0200) 2004; 17
Sanchez-Prieto, Rojas, Taya, Gutkind (bib0425) 2000; 60
Safavi, Li, Gonnella, Mari, Rasouli, Zhang, Rostami (bib0040) 2015; 61
Mokhtari, Li, Lu, Welsh (bib0275) 2011; 6
Netzer, Dou, Cai, Veach, Jean, Li, Bornmann, Clarkson, Xu, Greengard (bib0205) 2003; 100
Shiba, Fujimoto, Imanaka-Yoshida, Yoshida, Taki, Suzuki (bib0345) 2014; 5
Sanchez-Arévalo Lobo, Aceves Luquero, Alvarez-Vallina, Tipping, Viniegra, Hernández Losa, Parada Cobo, Galán Moya, Gayoso Cruz, Melo, Ramón y Cajal, Sánchez-Prieto (bib0415) 2005; 387
Hussain, Fabrègue, Anderes, Ousson, Borlat, Eligert, Berger, Dimitrov, Alattia, Fraering, Beher (bib0215) 2013; 288
Sahni, Weinberger (bib0320) 2007; 3
Su, Cao, Fredriksson, Nilsson, Stefanitsch, Stevenson, Zhao, Ragsdale, Sun, Yepes, Kuan, Eriksson, Strickland, Lawrence, Zhang (bib0315) 2017; 134
Neugroschl, Wang (bib0095) 2011; 78
Bath, Lees (bib0260) 2000; 173
Abrams, Nilsson, Lewandowski, Kjell, Codeluppi, Olson, Eriksson (bib0085) 2012; 7
Cao, Sudhof (bib0245) 2001; 293
Ciarcia, Vitiello, Galdiero, Pacilio, Iovane, d’Angelo, Pagnini, Caparrotti, Conti, Tomei, Florio, Giordano (bib0280) 2012; 227
Hirano, Greengard, Huganir (bib0035) 1988; 50
Gasser (bib0380) 2009; 27
Cancino, Toledo, Leal, Hernandez, Yévenes, Inestrosa, Alvarez (bib0150) 2008; 131
Su, Fredriksson, Kanzawa, Moore, Folestad, Stevenson, Nilsson, Sashindranath, Schielke, Warnock, Ragsdale, Mann, Lawrence, Medcalf, Eriksson, Murphy, Lawrence (bib0335) 2015; 7
Szybinska, Lesniak (bib0435) 2017; 8
De-Paula, Radanovic, Diniz, Forlenza (bib0090) 2012; 65
Savitt, Dawson, Dawson (bib0375) 2006; 116
Cuadrado, Nebreda (bib0400) 2010; 429
Takayama, Sato, O’Brien, Ikeda, Okamoto (bib0135) 2002; 119
Wolff, Richardson, Egorin, Ilaria (bib0140) 2003; 101
Paul, Mukhopadhyay (bib0030) 2004; 1
Zakaria, Wan Yaacob, Othman, Long, Ahmad, Al-Rahbi (bib0105) 2017; 66
Shimoji, Zhang, Mandir, Dawson, Dawson (bib0390) 2005; 134
Alves da Costa, Dunys, Brau, Wilk, Cappai, Checler (bib0460) 2006; 281
Su, Fredriksson, Geyer, Folestad, Cale, Andrae, Gao, Pietras, Mann, Yepes, Strickland, Betsholtz, Eriksson, Lawrence (bib0050) 2008; 14
Alzforum (bib0175)
Carson, Turner (bib0230) 2002; 81
Pandey, Raingeaud, Kaneki, Weichselbaum, Davis, Kufe, Kharbanda (bib0410) 1996; 271
Ben Ami, Demetri (bib0010) 2016; 15
Lee, Lee, Yuk, Choi, Ban, Oh, Hong (bib0125) 2008; 29
Weintraub, Bisson, Nouri, Vinson, Eimerbrink, Kranjac, Boehm, Chumley (bib0110) 2013; 33
Bauer, Pardossi-Piquard, Dunys, Roy, Checler (bib0250) 2011; 27
Aho, Harmsen, Hatano, Marquardsen, Smirnov, Strasser (bib0255) 1980; 58
Hafez, Huang, Huynh, Valtierra, Rockenstein, Bruno, Lu, DesGroseillers, Masliah, Marr (bib0235) 2011; 178
Crespo, Kang, Daneman, Lindstrom, Ho, Sobel, Steinman, Robinson (bib0365) 2011; 31
Gambhir, Vyas, Hollis, Aekka, Vyas (bib0290) 2015; 21
Blandini, Armentero (bib0385) 2012; 279
Moawad (bib0350) 2014; 29
Changlong, Guangwei, Xuenong, Xiaohui, Xiaochuan, Yanfeng (bib0330) 2016; 25
Kitazawa, Oddo, Yamasaki, Green, LaFerla (bib0130) 2005; 25
Pardossi-Piquard, Petit, Kawarai, Sunyach, Alves da Costa, Vincent, Ring, D’Adamio, Shen, Müller, St George Hyslop, Checler (bib0240) 2005; 46
Waller (bib0020) 2010; 184
Zarubin, Han (bib0395) 2005; 15
Karunakaran, Saeed, Mishra, Valli, Joshi, Meka, Seth, Ravindranath (bib0440) 2008; 28
Eisele, Baumann, Klebl, Nordhammer, Jucker, Kilger (bib0220) 2007; 18
Passer, Pellegrini, Russo, Siegel, Lenardo, Schettini, Bachmann, Tabaton, D’Adamio (bib0225) 2000; 2
Olsson, Legros, Guilhot, Strömberg, Smith, Livesey, Wilson, Zetterberg, Blennow (bib0180) 2014; 10
Tu, Okamoto, Lipton, Xu (bib0185) 2014; 14
Wu (10.1016/j.phrs.2019.03.014_bib0445) 2013; 63
Bengoa-Vergniory (10.1016/j.phrs.2019.03.014_bib0450) 2017; 134
Cao (10.1016/j.phrs.2019.03.014_bib0245) 2001; 293
Freeman (10.1016/j.phrs.2019.03.014_bib0310) 2014; 27
Alvarez (10.1016/j.phrs.2019.03.014_bib0200) 2004; 17
Sanchez-Arévalo Lobo (10.1016/j.phrs.2019.03.014_bib0415) 2005; 387
Oddo (10.1016/j.phrs.2019.03.014_bib0160) 2003; 39
Joice (10.1016/j.phrs.2019.03.014_bib0295) 2009; 17
Szybinska (10.1016/j.phrs.2019.03.014_bib0435) 2017; 8
Changlong (10.1016/j.phrs.2019.03.014_bib0330) 2016; 25
Zhan (10.1016/j.phrs.2019.03.014_bib0060) 2015; 93
Crespo (10.1016/j.phrs.2019.03.014_bib0365) 2011; 31
Jacobsen (10.1016/j.phrs.2019.03.014_bib0370) 2018; 13
El-Deiry (10.1016/j.phrs.2019.03.014_bib0430) 1992; 1
Adzemovic (10.1016/j.phrs.2019.03.014_bib0065) 2013; 8
Eisele (10.1016/j.phrs.2019.03.014_bib0220) 2007; 18
Shiba (10.1016/j.phrs.2019.03.014_bib0340) 2012; 46
Netzer (10.1016/j.phrs.2019.03.014_bib0210) 2017; 114
Galan-Moya (10.1016/j.phrs.2019.03.014_bib0420) 2008; 122
Wu (10.1016/j.phrs.2019.03.014_bib0070) 2016; 23
Sahni (10.1016/j.phrs.2019.03.014_bib0320) 2007; 3
Gambhir (10.1016/j.phrs.2019.03.014_bib0290) 2015; 21
Gardner (10.1016/j.phrs.2019.03.014_bib0115) 2016; 7
Cancino (10.1016/j.phrs.2019.03.014_bib0150) 2008; 131
Savage (10.1016/j.phrs.2019.03.014_bib0015) 2002; 346
Mokhtari (10.1016/j.phrs.2019.03.014_bib0275) 2011; 6
Su (10.1016/j.phrs.2019.03.014_bib0315) 2017; 134
Parmar (10.1016/j.phrs.2019.03.014_bib0265) 2011; 3
Su (10.1016/j.phrs.2019.03.014_bib0050) 2008; 14
Su (10.1016/j.phrs.2019.03.014_bib0335) 2015; 7
Passer (10.1016/j.phrs.2019.03.014_bib0225) 2000; 2
Wahlgren (10.1016/j.phrs.2019.03.014_bib0305) 2017; 281
Lee (10.1016/j.phrs.2019.03.014_bib0125) 2008; 29
Estrada (10.1016/j.phrs.2019.03.014_bib0155) 2016; 54
Hafez (10.1016/j.phrs.2019.03.014_bib0235) 2011; 178
Alves Da Costa (10.1016/j.phrs.2019.03.014_bib0455) 2002; 277
Takayama (10.1016/j.phrs.2019.03.014_bib0135) 2002; 119
Karunakaran (10.1016/j.phrs.2019.03.014_bib0440) 2008; 28
Hirano (10.1016/j.phrs.2019.03.014_bib0035) 1988; 50
Mahad (10.1016/j.phrs.2019.03.014_bib0360) 2006; 129
Baccarani (10.1016/j.phrs.2019.03.014_bib0005) 2006; 108
Safavi (10.1016/j.phrs.2019.03.014_bib0040) 2015; 61
Zarubin (10.1016/j.phrs.2019.03.014_bib0395) 2005; 15
Sutcliffe (10.1016/j.phrs.2019.03.014_bib0145) 2011; 89
Qureshi (10.1016/j.phrs.2019.03.014_bib0325) 2009; 373
Druker (10.1016/j.phrs.2019.03.014_bib0025) 2001; 344
Abrams (10.1016/j.phrs.2019.03.014_bib0085) 2012; 7
Julien (10.1016/j.phrs.2019.03.014_bib0190) 2018; 6
Wu (10.1016/j.phrs.2019.03.014_bib0045) 2014; 7
Hussain (10.1016/j.phrs.2019.03.014_bib0215) 2013; 288
Merali (10.1016/j.phrs.2019.03.014_bib0270) 2015; 6
Blandini (10.1016/j.phrs.2019.03.014_bib0385) 2012; 279
Cancino (10.1016/j.phrs.2019.03.014_bib0075) 2011; 32
Kegel (10.1016/j.phrs.2019.03.014_bib0080) 2010; 14
Weintraub (10.1016/j.phrs.2019.03.014_bib0110) 2013; 33
Apostolova (10.1016/j.phrs.2019.03.014_bib0100) 2016; 22
Qi (10.1016/j.phrs.2019.03.014_bib0195) 2018
Pardossi-Piquard (10.1016/j.phrs.2019.03.014_bib0240) 2005; 46
He (10.1016/j.phrs.2019.03.014_bib0165) 2010; 467
Paul (10.1016/j.phrs.2019.03.014_bib0030) 2004; 1
Zakaria (10.1016/j.phrs.2019.03.014_bib0105) 2017; 66
Shimoji (10.1016/j.phrs.2019.03.014_bib0390) 2005; 134
Witiw (10.1016/j.phrs.2019.03.014_bib0465) 2015; 28
Pandey (10.1016/j.phrs.2019.03.014_bib0410) 1996; 271
Netzer (10.1016/j.phrs.2019.03.014_bib0205) 2003; 100
Olsson (10.1016/j.phrs.2019.03.014_bib0180) 2014; 10
Waller (10.1016/j.phrs.2019.03.014_bib0020) 2010; 184
Neugroschl (10.1016/j.phrs.2019.03.014_bib0095) 2011; 78
Tu (10.1016/j.phrs.2019.03.014_bib0185) 2014; 14
Bath (10.1016/j.phrs.2019.03.014_bib0260) 2000; 173
Tak (10.1016/j.phrs.2019.03.014_bib0285) 2001; 107
Hsuchou (10.1016/j.phrs.2019.03.014_bib0300) 2012; 30
Shiba (10.1016/j.phrs.2019.03.014_bib0345) 2014; 5
Cuadrado (10.1016/j.phrs.2019.03.014_bib0400) 2010; 429
Carson (10.1016/j.phrs.2019.03.014_bib0230) 2002; 81
Aho (10.1016/j.phrs.2019.03.014_bib0255) 1980; 58
Kitazawa (10.1016/j.phrs.2019.03.014_bib0130) 2005; 25
Savitt (10.1016/j.phrs.2019.03.014_bib0375) 2006; 116
Ben Ami (10.1016/j.phrs.2019.03.014_bib0010) 2016; 15
Ma (10.1016/j.phrs.2019.03.014_bib0055) 2011; 70
Alzforum (10.1016/j.phrs.2019.03.014_bib0175)
Azizi (10.1016/j.phrs.2019.03.014_bib0355) 2014; 13
Kahn (10.1016/j.phrs.2019.03.014_bib0120) 2012; 229
Wolff (10.1016/j.phrs.2019.03.014_bib0140) 2003; 101
Chu (10.1016/j.phrs.2019.03.014_bib0170) 2014; 41
Gasser (10.1016/j.phrs.2019.03.014_bib0380) 2009; 27
Sanchez-Prieto (10.1016/j.phrs.2019.03.014_bib0425) 2000; 60
De-Paula (10.1016/j.phrs.2019.03.014_bib0090) 2012; 65
Moawad (10.1016/j.phrs.2019.03.014_bib0350) 2014; 29
Liu (10.1016/j.phrs.2019.03.014_bib0405) 2017; 2
Bauer (10.1016/j.phrs.2019.03.014_bib0250) 2011; 27
Ciarcia (10.1016/j.phrs.2019.03.014_bib0280) 2012; 227
Alves da Costa (10.1016/j.phrs.2019.03.014_bib0460) 2006; 281
References_xml – volume: 27
  start-page: 63
  year: 2014
  end-page: 73
  ident: bib0310
  article-title: t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions
  publication-title: Brain Res.
– volume: 25
  start-page: 2203
  year: 2016
  end-page: 2208
  ident: bib0330
  article-title: The role of platelet-derived growth factor receptor in early brain injury following subarachnoid hemorrhage
  publication-title: J. Stroke Cerebrovasc. Dis.
– volume: 429
  start-page: 403
  year: 2010
  end-page: 417
  ident: bib0400
  article-title: Mechanisms and functions of p38 MAPK signalling
  publication-title: Biochem. J.
– volume: 1
  start-page: 101
  year: 2004
  end-page: 115
  ident: bib0030
  article-title: Tyrosine kinase - Role and significance in Cancer
  publication-title: Int. J. Med. Sci.
– volume: 70
  start-page: 920
  year: 2011
  end-page: 931
  ident: bib0055
  article-title: PDGFR-α inhibition preserves blood-brain barrier after intracerebral hemorrhage
  publication-title: Ann. Neurol.
– volume: 66
  start-page: 553
  year: 2017
  end-page: 565
  ident: bib0105
  article-title: Lipopolysaccharide-induced memory impairment in rats: a model of Alzheimer’s disease
  publication-title: Physiol. Res.
– volume: 8
  start-page: 506
  year: 2017
  end-page: 518
  ident: bib0435
  article-title: P53 Dysfunction in Neurodegenerative Diseases - The Cause or Effect of Pathological Changes?
  publication-title: Aging Dis.
– volume: 271
  start-page: 23775
  year: 1996
  end-page: 23779
  ident: bib0410
  article-title: Activation of p38 mitogen-activated protein kinase by c-Abl-dependent and -independent mechanisms
  publication-title: J. Biol. Chem.
– volume: 122
  start-page: 289
  year: 2008
  end-page: 297
  ident: bib0420
  article-title: Abl activates p38 MAPK independently of its tyrosine kinase activity: Implications in cisplatin-based therapy
  publication-title: Int. J. Cancer
– volume: 101
  start-page: 5010
  year: 2003
  end-page: 5013
  ident: bib0140
  article-title: The CNS is a sanctuary for leukemic cells in mice receiving imatinib mesylate for Bcr/Abl-induced leukemia
  publication-title: Blood
– volume: 13
  start-page: 198
  year: 2014
  end-page: 206
  ident: bib0355
  article-title: Effects of imatinib mesylate in mouse models of multiple sclerosis and in vitro determinants
  publication-title: Iran. J. Allergy Asthma Immunol.
– volume: 2
  start-page: 1597
  year: 2017
  end-page: 1606
  ident: bib0405
  article-title: MicroRNA-181a regulates apoptosis and autophagy process in parkinson’s disease by inhibiting p38 mitogen-activated protein kinase (MAPK)/c-Jun N-Terminal kinases (JNK) signaling pathways
  publication-title: Med. Sci. Monit.
– volume: 279
  start-page: 1156
  year: 2012
  end-page: 1166
  ident: bib0385
  article-title: Animal models of Parkinson’s disease
  publication-title: FEBS J.
– volume: 27
  start-page: 511
  year: 2011
  end-page: 520
  ident: bib0250
  article-title: γ-Secretase-mediated regulation of neprilysin: influence of cell density and aging and modulation by imatinib
  publication-title: J. Alzheimers Dis.
– volume: 18
  start-page: 3591
  year: 2007
  end-page: 3600
  ident: bib0220
  article-title: Gleevec increases levels of the amyloid precursor protein intracellular domain and of the amyloid-beta degrading enzyme neprilysin
  publication-title: Mol. Biol. Cell
– volume: 6
  start-page: 131
  year: 2018
  ident: bib0190
  article-title: In vivo induction of membrane damage by β-amyloid peptide oligomers
  publication-title: Acta Neuropathol. Commun.
– volume: 134
  start-page: 819
  year: 2017
  end-page: 838
  ident: bib0450
  article-title: Alpha-synuclein oligomers: a new hope
  publication-title: Acta Neuropathol.
– volume: 14
  start-page: 48
  year: 2014
  ident: bib0185
  article-title: Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s’s disease
  publication-title: Mol. Neurodegener.
– volume: 173
  start-page: 209
  year: 2000
  end-page: 212
  ident: bib0260
  article-title: Acute stroke
  publication-title: West. J. Med.
– year: 2018
  ident: bib0195
  article-title: Intracerebroventricular injection of resveratrol ameliorated Aβ-induced learning and cognitive decline in mice
  publication-title: Metab. Brain Dis.
– volume: 81
  start-page: 1
  year: 2002
  end-page: 8
  ident: bib0230
  article-title: Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?
  publication-title: J. Neurochem.
– volume: 89
  start-page: 808
  year: 2011
  end-page: 814
  ident: bib0145
  article-title: Peripheral reduction of β-amyloid is sufficient to reduce brain β-amyloid: implications for Alzheimer’s disease
  publication-title: J. Neurosci. Res.
– volume: 134
  start-page: 103
  year: 2005
  end-page: 108
  ident: bib0390
  article-title: Absence of inclusion body formation in the MPTP mouse model of Parkinson’s disease
  publication-title: Brain Res. Mol. Brain Res.
– volume: 131
  start-page: 2425
  year: 2008
  end-page: 2442
  ident: bib0150
  article-title: STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer’s beta-amyloid deposits
  publication-title: Brain
– volume: 33
  start-page: 24
  year: 2013
  end-page: 28
  ident: bib0110
  article-title: Imatinib methanesulfonate reduces hippocampal amyloid-β and restores cognitive function following repeated endotoxin exposure
  publication-title: Brain Behav. Immun.
– volume: 281
  start-page: 273
  year: 2017
  end-page: 283
  ident: bib0305
  article-title: Randomized assessment of imatinib in patients with acute ischaemic stroke treated with intravenous thrombolysis
  publication-title: J. Intern. Med.
– volume: 17
  start-page: 13
  year: 2009
  end-page: 23
  ident: bib0295
  article-title: Modulation of blood-brain barrier permeability by neutrophils: in vitro and in vivo studies
  publication-title: Brain Res.
– volume: 184
  start-page: 3
  year: 2010
  end-page: 20
  ident: bib0020
  article-title: Imatinib mesylate
  publication-title: Recent Results Cancer Res.
– volume: 3
  start-page: 701
  year: 2007
  end-page: 709
  ident: bib0320
  article-title: Management of intracerebral hemorrhage
  publication-title: Vasc. Health Risk Manag.
– volume: 93
  start-page: 94
  year: 2015
  end-page: 103
  ident: bib0060
  article-title: Imatinib preserves blood-brain barrier integrity following experimental subarachnoid hemorrhage in rats
  publication-title: J. Neurosci. Res.
– volume: 1
  start-page: 45
  year: 1992
  end-page: 49
  ident: bib0430
  article-title: Definition of a consensus binding site for p53
  publication-title: Nat. Genet.
– volume: 119
  start-page: 106
  year: 2002
  end-page: 108
  ident: bib0135
  article-title: Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome-positive acute lymphoblastic leukaemia due to poor penetration into cerebrospinal fluid
  publication-title: Br. J. Haematol.
– volume: 15
  start-page: 11
  year: 2005
  end-page: 18
  ident: bib0395
  article-title: Activation and signaling of the p38 MAP kinase pathway
  publication-title: Cell Res.
– volume: 65
  start-page: 329
  year: 2012
  end-page: 352
  ident: bib0090
  article-title: Alzheimer’s disease
  publication-title: Subcell. Biochem.
– volume: 344
  start-page: 1031
  year: 2001
  end-page: 1037
  ident: bib0025
  article-title: Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
  publication-title: N. Engl. J. Med.
– volume: 46
  start-page: 172
  year: 2012
  end-page: 179
  ident: bib0340
  article-title: Imatinib mesylate prevents cerebral vasospasm after subarachnoid hemorrhage via inhibiting tenascin-C expression in rats
  publication-title: Neurobiol. Dis.
– volume: 29
  start-page: 491
  year: 2014
  end-page: 495
  ident: bib0350
  article-title: Induction of multiple sclerosis and response to tyrosine kinase inhibitors
  publication-title: Indian J. Clin. Biochem.
– volume: 281
  start-page: 9824
  year: 2006
  end-page: 9831
  ident: bib0460
  article-title: 6-Hydroxydopamine but not 1-methyl-4-phenylpyridinium abolishes alpha-synuclein anti-apoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation
  publication-title: J. Biol. Chem.
– volume: 58
  start-page: 113
  year: 1980
  end-page: 130
  ident: bib0255
  article-title: Cerebrovascular disease in the community: results of a WHO collaborative study
  publication-title: Bull. World Health Organ.
– volume: 60
  start-page: 2464
  year: 2000
  end-page: 2472
  ident: bib0425
  article-title: A role for the p38 mitogen-acitvated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents
  publication-title: Cancer Res.
– volume: 15
  start-page: 571
  year: 2016
  end-page: 578
  ident: bib0010
  article-title: A safety evaluation of imatinib mesylate in the treatment of gastrointestinal stromal tumor
  publication-title: Expert Opin. Drug Saf.
– volume: 10
  start-page: S374
  year: 2014
  end-page: 380
  ident: bib0180
  article-title: Imatinib treatment and Aβ42 in humans
  publication-title: Alzheimers Dement.
– volume: 116
  start-page: 1744
  year: 2006
  end-page: 1754
  ident: bib0375
  article-title: Diagnosis and treatment of Parkinson disease: molecules to medicine
  publication-title: J. Clin. Invest.
– volume: 54
  start-page: 1193
  year: 2016
  end-page: 1205
  ident: bib0155
  article-title: Reduction of blood Amyloid-β oligomers in Alzheimer’s disease transgenic mice by c-Abl kinase inhibition
  publication-title: J. Alzheimers Dis.
– volume: 30
  start-page: 1109
  year: 2012
  end-page: 1119
  ident: bib0300
  article-title: C-reactive protein increases BBB permeability: implications for obesity and neuroinflammation
  publication-title: Cell. Physiol. Biochem.
– volume: 373
  start-page: 1632
  year: 2009
  end-page: 1644
  ident: bib0325
  article-title: Intracerebral haemorrhage
  publication-title: Lancet
– volume: 50
  start-page: 1447
  year: 1988
  end-page: 1455
  ident: bib0035
  article-title: Protein tyrosine kinase activity and its endogenous substrates in rat brain: a subcellular and regional survey
  publication-title: J. Neurochem.
– volume: 32
  start-page: 1249
  year: 2011
  end-page: 1261
  ident: bib0075
  article-title: c-Abl tyrosine kinase modulates tau pathology and Cdk5 phosphorylation in AD transgenic mice
  publication-title: Neurobiol. Aging
– volume: 28
  start-page: 12500
  year: 2008
  end-page: 12509
  ident: bib0440
  article-title: Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice
  publication-title: J. Neurosci.
– volume: 7
  start-page: 5505
  year: 2014
  end-page: 5514
  ident: bib0045
  article-title: Intranasal sirna targeting c-kit reduces airway inflammation in experimental allergic asthma
  publication-title: Int. J. Clin. Exp. Pathol.
– volume: 63
  start-page: 133
  year: 2013
  end-page: 140
  ident: bib0445
  article-title: p38(MAPK)/p53-Mediated Bax induction contributes to neurons degeneration in rotenone-induced cellular and rat models of Parkinson’s disease
  publication-title: Neurochem. Int.
– volume: 107
  start-page: 7
  year: 2001
  end-page: 11
  ident: bib0285
  article-title: NF-kB: a key role in inflammatory diseases
  publication-title: J. Clin. Invest.
– volume: 387
  start-page: 231
  year: 2005
  end-page: 238
  ident: bib0415
  article-title: Modulation of the p38 MAPK (mitogen-activated protein kinase) pathway through Bcr/Abl: implications in the cellular response to Ara-C
  publication-title: Biochem. J.
– volume: 61
  start-page: 294
  year: 2015
  end-page: 302
  ident: bib0040
  article-title: c-kit plays a critical role in induction of intravenous tolerance in experimental autoimmune encephalomyelitis
  publication-title: Immunol. Res.
– volume: 6
  start-page: 39
  year: 2015
  end-page: 49
  ident: bib0270
  article-title: Longitudinal assessment of imatinib’s effect on the blood-brain barrier after ischemia/reperfusion injury with permeability MRI
  publication-title: Transl. Stroke Res.
– volume: 14
  start-page: 58
  year: 2010
  ident: bib0080
  article-title: Huntingtin cleavage product A forms in neurons and is reduced by gamma-secretase inhibitors
  publication-title: Mol. Neurodegener.
– volume: 277
  start-page: 50980
  year: 2002
  end-page: 50984
  ident: bib0455
  article-title: Alpha-synuclein lowers p53-dependent apoptotic response of neuronal cells
  publication-title: J. Biol. Chem.
– volume: 39
  start-page: 409
  year: 2003
  end-page: 421
  ident: bib0160
  article-title: Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction
  publication-title: Neuron
– volume: 346
  start-page: 683
  year: 2002
  end-page: 693
  ident: bib0015
  article-title: Imatinib mesylate--a new oral targeted therapy
  publication-title: N. Engl. J. Med.
– volume: 22
  start-page: 419
  year: 2016
  end-page: 434
  ident: bib0100
  article-title: Alzheimer’s disease
  publication-title: Continuum (Minneap Minn)
– volume: 114
  start-page: 1389
  year: 2017
  end-page: 1394
  ident: bib0210
  article-title: Gleevec shifts APP processing from a β-cleavage to a nonamyloidogenic cleavage
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 229
  start-page: 176
  year: 2012
  end-page: 184
  ident: bib0120
  article-title: Prolonged elevation in hippocampal Aβ and cognitive deficits following repeated endotoxin exposure in the mouse
  publication-title: Behav. Brain Res.
– volume: 134
  start-page: 585
  year: 2017
  end-page: 604
  ident: bib0315
  article-title: Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke
  publication-title: Acta Neuropathol.
– volume: 29
  start-page: 37
  year: 2008
  ident: bib0125
  article-title: Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation
  publication-title: J. Neuroinflammation
– volume: 7
  year: 2012
  ident: bib0085
  article-title: Imatinib enhances functional outcome after spinal cord injury
  publication-title: PLoS One
– volume: 17
  start-page: 326
  year: 2004
  end-page: 336
  ident: bib0200
  article-title: Activation of the neuronal c-Abl tyrosine kinase by amyloid-beta-peptide and reactive oxygen species
  publication-title: Neurobiol. Dis.
– volume: 46
  start-page: 541
  year: 2005
  end-page: 554
  ident: bib0240
  article-title: Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP
  publication-title: Neuron
– volume: 288
  start-page: 2521
  year: 2013
  end-page: 2531
  ident: bib0215
  article-title: The role of γ-secretase activating protein (GSAP) and imatinib in the regulation of γ-secretase activity and amyloid-β generation
  publication-title: J. Biol. Chem.
– volume: 27
  start-page: e22
  year: 2009
  ident: bib0380
  article-title: Molecular pathogenesis of Parkinson disease: insights from genetic studies
  publication-title: Expert Rev. Mol. Med.
– volume: 7
  start-page: 72
  year: 2016
  end-page: 77
  ident: bib0115
  article-title: Imatinib methanesulfonate reduces hyperphosphorylation of tau following repeated peripheral exposure to lipopolysaccharide
  publication-title: Neuroscience
– volume: 25
  start-page: 8843
  year: 2005
  end-page: 8853
  ident: bib0130
  article-title: Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer’s disease
  publication-title: J. Neurosci.
– volume: 21
  start-page: 3174
  year: 2015
  end-page: 3183
  ident: bib0290
  article-title: Nuclear factor kappa B role in inflammation associated gastrointestinal malignancies
  publication-title: World J. Gastroenterol.
– volume: 6
  year: 2011
  ident: bib0275
  article-title: Effects of Imatinib Mesylate (Gleevec) on human islet NF-kappaB activation and chemokine production in vitro
  publication-title: PLoS One
– volume: 293
  start-page: 115
  year: 2001
  end-page: 120
  ident: bib0245
  article-title: A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60
  publication-title: Science
– volume: 13
  start-page: 265
  year: 2018
  end-page: 276
  ident: bib0370
  article-title: A role for the non-receptor tyrosine kinase Abl2/Arg in experimental neuroinflammation
  publication-title: J. Neuroimmune Pharmacol.
– volume: 3
  start-page: 200
  year: 2011
  ident: bib0265
  article-title: Stroke: classification and diagnosis
  publication-title: Clin. Pharm.
– volume: 2
  start-page: 289
  year: 2000
  end-page: 301
  ident: bib0225
  article-title: Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer’s amyloid beta protein precursor
  publication-title: J. Alzheimers Dis.
– volume: 129
  start-page: 212
  year: 2006
  end-page: 223
  ident: bib0360
  article-title: Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis
  publication-title: Brain
– volume: 100
  start-page: 12444
  year: 2003
  end-page: 12449
  ident: bib0205
  article-title: Gleevec inhibits beta-amyloid production but not Notch cleavage
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 467
  start-page: 95
  year: 2010
  end-page: 98
  ident: bib0165
  article-title: Gamma-secretase activating protein is a therapeutic target for Alzheimer’s disease
  publication-title: Nature
– volume: 7
  start-page: 385
  year: 2015
  ident: bib0335
  article-title: Imatinib treatment reduces brain injury in a murine model of traumatic brain injury
  publication-title: Front. Cell. Neurosci.
– volume: 8
  year: 2013
  ident: bib0065
  article-title: Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response
  publication-title: PLoS One
– volume: 5
  start-page: 238
  year: 2014
  end-page: 247
  ident: bib0345
  article-title: Tenascin-C causes neuronal apoptosis after subarachnoid hemorrhage in rats
  publication-title: Transl. Stroke Res.
– volume: 14
  start-page: 731
  year: 2008
  end-page: 737
  ident: bib0050
  article-title: Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke
  publication-title: Nat. Med.
– ident: bib0175
  article-title: GSAP Revisited: Does It Really Play a Role in Processing Aβ
– volume: 108
  start-page: 1809
  year: 2006
  end-page: 1820
  ident: bib0005
  article-title: European LeukemiaNet. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
  publication-title: Blood
– volume: 178
  start-page: 306
  year: 2011
  end-page: 312
  ident: bib0235
  article-title: Neprilysin-2 is an important β-amyloid degrading enzyme
  publication-title: Am. J. Pathol.
– volume: 78
  start-page: 596
  year: 2011
  end-page: 612
  ident: bib0095
  article-title: Alzheimer’s disease: diagnosis and treatment across the spectrum of disease severity
  publication-title: Mt. Sinai J. Med.
– volume: 28
  start-page: 202
  year: 2015
  end-page: 210
  ident: bib0465
  article-title: Acute spinal cord injury
  publication-title: J. Spinal Disord. Tech.
– volume: 227
  start-page: 2798
  year: 2012
  end-page: 2803
  ident: bib0280
  article-title: Imatinib treatment inhibit IL-6, IL-8, NF-KB and AP-1 production and modulate intracellular calcium in CML patients
  publication-title: J. Cell. Physiol.
– volume: 23
  start-page: 542
  year: 2016
  end-page: 552
  ident: bib0070
  article-title: c-Abl–p38α signaling plays an important role in MPTP-induced neuronal death
  publication-title: Cell Death Differ.
– volume: 41
  start-page: 729
  year: 2014
  end-page: 737
  ident: bib0170
  article-title: Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer’s disease with plaques and tangles
  publication-title: J. Alzheimers Dis.
– volume: 31
  start-page: 1010
  year: 2011
  end-page: 1020
  ident: bib0365
  article-title: Tyrosine kinase inhibitors ameliorate autoimmune encephalomyelitis in a mouse model of multiple sclerosis
  publication-title: J. Clin. Immunol.
– volume: 346
  start-page: 683
  issue: February (9)
  year: 2002
  ident: 10.1016/j.phrs.2019.03.014_bib0015
  article-title: Imatinib mesylate--a new oral targeted therapy
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra013339
– volume: 10
  start-page: S374
  issue: October (5 Suppl)
  year: 2014
  ident: 10.1016/j.phrs.2019.03.014_bib0180
  article-title: Imatinib treatment and Aβ42 in humans
  publication-title: Alzheimers Dement.
– volume: 15
  start-page: 11
  issue: January (1
  year: 2005
  ident: 10.1016/j.phrs.2019.03.014_bib0395
  article-title: Activation and signaling of the p38 MAP kinase pathway
  publication-title: Cell Res.
  doi: 10.1038/sj.cr.7290257
– volume: 6
  issue: 9
  year: 2011
  ident: 10.1016/j.phrs.2019.03.014_bib0275
  article-title: Effects of Imatinib Mesylate (Gleevec) on human islet NF-kappaB activation and chemokine production in vitro
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0024831
– volume: 129
  start-page: 212
  issue: January (Pt 1)
  year: 2006
  ident: 10.1016/j.phrs.2019.03.014_bib0360
  article-title: Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis
  publication-title: Brain
  doi: 10.1093/brain/awh655
– volume: 14
  start-page: 48
  issue: November 9
  year: 2014
  ident: 10.1016/j.phrs.2019.03.014_bib0185
  article-title: Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s’s disease
  publication-title: Mol. Neurodegener.
  doi: 10.1186/1750-1326-9-48
– volume: 31
  start-page: 1010
  issue: December (6)
  year: 2011
  ident: 10.1016/j.phrs.2019.03.014_bib0365
  article-title: Tyrosine kinase inhibitors ameliorate autoimmune encephalomyelitis in a mouse model of multiple sclerosis
  publication-title: J. Clin. Immunol.
  doi: 10.1007/s10875-011-9579-6
– volume: 78
  start-page: 596
  issue: July-August (4)
  year: 2011
  ident: 10.1016/j.phrs.2019.03.014_bib0095
  article-title: Alzheimer’s disease: diagnosis and treatment across the spectrum of disease severity
  publication-title: Mt. Sinai J. Med.
  doi: 10.1002/msj.20279
– volume: 429
  start-page: 403
  issue: August (3)
  year: 2010
  ident: 10.1016/j.phrs.2019.03.014_bib0400
  article-title: Mechanisms and functions of p38 MAPK signalling
  publication-title: Biochem. J.
  doi: 10.1042/BJ20100323
– volume: 7
  start-page: 5505
  issue: August (9)
  year: 2014
  ident: 10.1016/j.phrs.2019.03.014_bib0045
  article-title: Intranasal sirna targeting c-kit reduces airway inflammation in experimental allergic asthma
  publication-title: Int. J. Clin. Exp. Pathol.
– volume: 8
  start-page: 506
  issue: July (4)
  year: 2017
  ident: 10.1016/j.phrs.2019.03.014_bib0435
  article-title: P53 Dysfunction in Neurodegenerative Diseases - The Cause or Effect of Pathological Changes?
  publication-title: Aging Dis.
  doi: 10.14336/AD.2016.1120
– volume: 33
  start-page: 24
  issue: October
  year: 2013
  ident: 10.1016/j.phrs.2019.03.014_bib0110
  article-title: Imatinib methanesulfonate reduces hippocampal amyloid-β and restores cognitive function following repeated endotoxin exposure
  publication-title: Brain Behav. Immun.
  doi: 10.1016/j.bbi.2013.05.002
– volume: 7
  issue: 6
  year: 2012
  ident: 10.1016/j.phrs.2019.03.014_bib0085
  article-title: Imatinib enhances functional outcome after spinal cord injury
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0038760
– volume: 100
  start-page: 12444
  issue: October (21)
  year: 2003
  ident: 10.1016/j.phrs.2019.03.014_bib0205
  article-title: Gleevec inhibits beta-amyloid production but not Notch cleavage
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1534745100
– volume: 25
  start-page: 8843
  issue: September (39)
  year: 2005
  ident: 10.1016/j.phrs.2019.03.014_bib0130
  article-title: Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer’s disease
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.2868-05.2005
– volume: 46
  start-page: 541
  issue: May (4)
  year: 2005
  ident: 10.1016/j.phrs.2019.03.014_bib0240
  article-title: Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP
  publication-title: Neuron
  doi: 10.1016/j.neuron.2005.04.008
– volume: 70
  start-page: 920
  issue: December (6)
  year: 2011
  ident: 10.1016/j.phrs.2019.03.014_bib0055
  article-title: PDGFR-α inhibition preserves blood-brain barrier after intracerebral hemorrhage
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.22549
– volume: 8
  issue: 2
  year: 2013
  ident: 10.1016/j.phrs.2019.03.014_bib0065
  article-title: Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0056586
– volume: 1
  start-page: 45
  issue: April (1)
  year: 1992
  ident: 10.1016/j.phrs.2019.03.014_bib0430
  article-title: Definition of a consensus binding site for p53
  publication-title: Nat. Genet.
  doi: 10.1038/ng0492-45
– volume: 344
  start-page: 1031
  issue: April (14)
  year: 2001
  ident: 10.1016/j.phrs.2019.03.014_bib0025
  article-title: Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM200104053441401
– volume: 58
  start-page: 113
  issue: 1
  year: 1980
  ident: 10.1016/j.phrs.2019.03.014_bib0255
  article-title: Cerebrovascular disease in the community: results of a WHO collaborative study
  publication-title: Bull. World Health Organ.
– volume: 14
  start-page: 58
  issue: December 5
  year: 2010
  ident: 10.1016/j.phrs.2019.03.014_bib0080
  article-title: Huntingtin cleavage product A forms in neurons and is reduced by gamma-secretase inhibitors
  publication-title: Mol. Neurodegener.
  doi: 10.1186/1750-1326-5-58
– volume: 134
  start-page: 103
  issue: March (1)
  year: 2005
  ident: 10.1016/j.phrs.2019.03.014_bib0390
  article-title: Absence of inclusion body formation in the MPTP mouse model of Parkinson’s disease
  publication-title: Brain Res. Mol. Brain Res.
  doi: 10.1016/j.molbrainres.2005.01.012
– volume: 119
  start-page: 106
  issue: October (1)
  year: 2002
  ident: 10.1016/j.phrs.2019.03.014_bib0135
  article-title: Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome-positive acute lymphoblastic leukaemia due to poor penetration into cerebrospinal fluid
  publication-title: Br. J. Haematol.
  doi: 10.1046/j.1365-2141.2002.03881.x
– volume: 101
  start-page: 5010
  issue: June (12)
  year: 2003
  ident: 10.1016/j.phrs.2019.03.014_bib0140
  article-title: The CNS is a sanctuary for leukemic cells in mice receiving imatinib mesylate for Bcr/Abl-induced leukemia
  publication-title: Blood
  doi: 10.1182/blood-2002-10-3059
– volume: 13
  start-page: 265
  issue: June (2)
  year: 2018
  ident: 10.1016/j.phrs.2019.03.014_bib0370
  article-title: A role for the non-receptor tyrosine kinase Abl2/Arg in experimental neuroinflammation
  publication-title: J. Neuroimmune Pharmacol.
  doi: 10.1007/s11481-018-9783-8
– volume: 18
  start-page: 3591
  issue: September (9)
  year: 2007
  ident: 10.1016/j.phrs.2019.03.014_bib0220
  article-title: Gleevec increases levels of the amyloid precursor protein intracellular domain and of the amyloid-beta degrading enzyme neprilysin
  publication-title: Mol. Biol. Cell
  doi: 10.1091/mbc.e07-01-0035
– volume: 293
  start-page: 115
  issue: July (5527)
  year: 2001
  ident: 10.1016/j.phrs.2019.03.014_bib0245
  article-title: A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60
  publication-title: Science
  doi: 10.1126/science.1058783
– volume: 41
  start-page: 729
  issue: 3
  year: 2014
  ident: 10.1016/j.phrs.2019.03.014_bib0170
  article-title: Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer’s disease with plaques and tangles
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-140105
– volume: 7
  start-page: 385
  issue: October 9
  year: 2015
  ident: 10.1016/j.phrs.2019.03.014_bib0335
  article-title: Imatinib treatment reduces brain injury in a murine model of traumatic brain injury
  publication-title: Front. Cell. Neurosci.
– volume: 29
  start-page: 491
  issue: October (4)
  year: 2014
  ident: 10.1016/j.phrs.2019.03.014_bib0350
  article-title: Induction of multiple sclerosis and response to tyrosine kinase inhibitors
  publication-title: Indian J. Clin. Biochem.
  doi: 10.1007/s12291-013-0387-z
– volume: 60
  start-page: 2464
  issue: May (9)
  year: 2000
  ident: 10.1016/j.phrs.2019.03.014_bib0425
  article-title: A role for the p38 mitogen-acitvated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents
  publication-title: Cancer Res.
– volume: 288
  start-page: 2521
  issue: January (4)
  year: 2013
  ident: 10.1016/j.phrs.2019.03.014_bib0215
  article-title: The role of γ-secretase activating protein (GSAP) and imatinib in the regulation of γ-secretase activity and amyloid-β generation
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M112.370924
– volume: 277
  start-page: 50980
  issue: December (52)
  year: 2002
  ident: 10.1016/j.phrs.2019.03.014_bib0455
  article-title: Alpha-synuclein lowers p53-dependent apoptotic response of neuronal cells
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M207825200
– volume: 227
  start-page: 2798
  issue: June (6)
  year: 2012
  ident: 10.1016/j.phrs.2019.03.014_bib0280
  article-title: Imatinib treatment inhibit IL-6, IL-8, NF-KB and AP-1 production and modulate intracellular calcium in CML patients
  publication-title: J. Cell. Physiol.
  doi: 10.1002/jcp.23029
– volume: 5
  start-page: 238
  issue: April (2)
  year: 2014
  ident: 10.1016/j.phrs.2019.03.014_bib0345
  article-title: Tenascin-C causes neuronal apoptosis after subarachnoid hemorrhage in rats
  publication-title: Transl. Stroke Res.
  doi: 10.1007/s12975-014-0333-2
– volume: 14
  start-page: 731
  issue: July (7)
  year: 2008
  ident: 10.1016/j.phrs.2019.03.014_bib0050
  article-title: Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke
  publication-title: Nat. Med.
  doi: 10.1038/nm1787
– ident: 10.1016/j.phrs.2019.03.014_bib0175
– volume: 27
  start-page: 63
  issue: May 1565
  year: 2014
  ident: 10.1016/j.phrs.2019.03.014_bib0310
  article-title: t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions
  publication-title: Brain Res.
  doi: 10.1016/j.brainres.2014.03.027
– volume: 54
  start-page: 1193
  issue: October (3)
  year: 2016
  ident: 10.1016/j.phrs.2019.03.014_bib0155
  article-title: Reduction of blood Amyloid-β oligomers in Alzheimer’s disease transgenic mice by c-Abl kinase inhibition
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-151087
– volume: 178
  start-page: 306
  issue: January (1)
  year: 2011
  ident: 10.1016/j.phrs.2019.03.014_bib0235
  article-title: Neprilysin-2 is an important β-amyloid degrading enzyme
  publication-title: Am. J. Pathol.
  doi: 10.1016/j.ajpath.2010.11.012
– volume: 387
  start-page: 231
  issue: April (Pt 1)
  year: 2005
  ident: 10.1016/j.phrs.2019.03.014_bib0415
  article-title: Modulation of the p38 MAPK (mitogen-activated protein kinase) pathway through Bcr/Abl: implications in the cellular response to Ara-C
  publication-title: Biochem. J.
  doi: 10.1042/BJ20040927
– volume: 93
  start-page: 94
  issue: January (1)
  year: 2015
  ident: 10.1016/j.phrs.2019.03.014_bib0060
  article-title: Imatinib preserves blood-brain barrier integrity following experimental subarachnoid hemorrhage in rats
  publication-title: J. Neurosci. Res.
  doi: 10.1002/jnr.23475
– volume: 25
  start-page: 2203
  issue: September (9)
  year: 2016
  ident: 10.1016/j.phrs.2019.03.014_bib0330
  article-title: The role of platelet-derived growth factor receptor in early brain injury following subarachnoid hemorrhage
  publication-title: J. Stroke Cerebrovasc. Dis.
– volume: 229
  start-page: 176
  issue: April (1)
  year: 2012
  ident: 10.1016/j.phrs.2019.03.014_bib0120
  article-title: Prolonged elevation in hippocampal Aβ and cognitive deficits following repeated endotoxin exposure in the mouse
  publication-title: Behav. Brain Res.
  doi: 10.1016/j.bbr.2012.01.010
– volume: 116
  start-page: 1744
  year: 2006
  ident: 10.1016/j.phrs.2019.03.014_bib0375
  article-title: Diagnosis and treatment of Parkinson disease: molecules to medicine
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI29178
– volume: 271
  start-page: 23775
  issue: September (39)
  year: 1996
  ident: 10.1016/j.phrs.2019.03.014_bib0410
  article-title: Activation of p38 mitogen-activated protein kinase by c-Abl-dependent and -independent mechanisms
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.271.39.23775
– volume: 184
  start-page: 3
  year: 2010
  ident: 10.1016/j.phrs.2019.03.014_bib0020
  article-title: Imatinib mesylate
  publication-title: Recent Results Cancer Res.
  doi: 10.1007/978-3-642-01222-8_1
– volume: 27
  start-page: 511
  issue: 3
  year: 2011
  ident: 10.1016/j.phrs.2019.03.014_bib0250
  article-title: γ-Secretase-mediated regulation of neprilysin: influence of cell density and aging and modulation by imatinib
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-2011-110746
– volume: 27
  start-page: e22
  issue: July 11
  year: 2009
  ident: 10.1016/j.phrs.2019.03.014_bib0380
  article-title: Molecular pathogenesis of Parkinson disease: insights from genetic studies
  publication-title: Expert Rev. Mol. Med.
  doi: 10.1017/S1462399409001148
– volume: 28
  start-page: 202
  issue: July (6)
  year: 2015
  ident: 10.1016/j.phrs.2019.03.014_bib0465
  article-title: Acute spinal cord injury
  publication-title: J. Spinal Disord. Tech.
  doi: 10.1097/BSD.0000000000000287
– volume: 1
  start-page: 101
  issue: 2
  year: 2004
  ident: 10.1016/j.phrs.2019.03.014_bib0030
  article-title: Tyrosine kinase - Role and significance in Cancer
  publication-title: Int. J. Med. Sci.
  doi: 10.7150/ijms.1.101
– volume: 108
  start-page: 1809
  issue: September (6)
  year: 2006
  ident: 10.1016/j.phrs.2019.03.014_bib0005
  article-title: European LeukemiaNet. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
  publication-title: Blood
  doi: 10.1182/blood-2006-02-005686
– volume: 107
  start-page: 7
  issue: January (1)
  year: 2001
  ident: 10.1016/j.phrs.2019.03.014_bib0285
  article-title: NF-kB: a key role in inflammatory diseases
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI11830
– volume: 13
  start-page: 198
  issue: June (3)
  year: 2014
  ident: 10.1016/j.phrs.2019.03.014_bib0355
  article-title: Effects of imatinib mesylate in mouse models of multiple sclerosis and in vitro determinants
  publication-title: Iran. J. Allergy Asthma Immunol.
– volume: 2
  start-page: 289
  issue: November (3-4)
  year: 2000
  ident: 10.1016/j.phrs.2019.03.014_bib0225
  article-title: Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer’s amyloid beta protein precursor
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-2000-23-408
– volume: 173
  start-page: 209
  issue: September (3)
  year: 2000
  ident: 10.1016/j.phrs.2019.03.014_bib0260
  article-title: Acute stroke
  publication-title: West. J. Med.
  doi: 10.1136/ewjm.173.3.209
– volume: 373
  start-page: 1632
  issue: May (9675)
  year: 2009
  ident: 10.1016/j.phrs.2019.03.014_bib0325
  article-title: Intracerebral haemorrhage
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)60371-8
– volume: 28
  start-page: 12500
  issue: November (47)
  year: 2008
  ident: 10.1016/j.phrs.2019.03.014_bib0440
  article-title: Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.4511-08.2008
– volume: 7
  start-page: 72
  issue: September 331
  year: 2016
  ident: 10.1016/j.phrs.2019.03.014_bib0115
  article-title: Imatinib methanesulfonate reduces hyperphosphorylation of tau following repeated peripheral exposure to lipopolysaccharide
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2016.06.007
– volume: 2
  start-page: 1597
  issue: April 23
  year: 2017
  ident: 10.1016/j.phrs.2019.03.014_bib0405
  article-title: MicroRNA-181a regulates apoptosis and autophagy process in parkinson’s disease by inhibiting p38 mitogen-activated protein kinase (MAPK)/c-Jun N-Terminal kinases (JNK) signaling pathways
  publication-title: Med. Sci. Monit.
  doi: 10.12659/MSM.900218
– volume: 89
  start-page: 808
  issue: June (6)
  year: 2011
  ident: 10.1016/j.phrs.2019.03.014_bib0145
  article-title: Peripheral reduction of β-amyloid is sufficient to reduce brain β-amyloid: implications for Alzheimer’s disease
  publication-title: J. Neurosci. Res.
  doi: 10.1002/jnr.22603
– volume: 279
  start-page: 1156
  issue: April (7)
  year: 2012
  ident: 10.1016/j.phrs.2019.03.014_bib0385
  article-title: Animal models of Parkinson’s disease
  publication-title: FEBS J.
  doi: 10.1111/j.1742-4658.2012.08491.x
– volume: 134
  start-page: 819
  issue: December (6)
  year: 2017
  ident: 10.1016/j.phrs.2019.03.014_bib0450
  article-title: Alpha-synuclein oligomers: a new hope
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-017-1755-1
– volume: 32
  start-page: 1249
  issue: July (7)
  year: 2011
  ident: 10.1016/j.phrs.2019.03.014_bib0075
  article-title: c-Abl tyrosine kinase modulates tau pathology and Cdk5 phosphorylation in AD transgenic mice
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2009.07.007
– volume: 281
  start-page: 273
  issue: March (3)
  year: 2017
  ident: 10.1016/j.phrs.2019.03.014_bib0305
  article-title: Randomized assessment of imatinib in patients with acute ischaemic stroke treated with intravenous thrombolysis
  publication-title: J. Intern. Med.
  doi: 10.1111/joim.12576
– volume: 39
  start-page: 409
  issue: July (3)
  year: 2003
  ident: 10.1016/j.phrs.2019.03.014_bib0160
  article-title: Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction
  publication-title: Neuron
  doi: 10.1016/S0896-6273(03)00434-3
– volume: 46
  start-page: 172
  issue: April (1)
  year: 2012
  ident: 10.1016/j.phrs.2019.03.014_bib0340
  article-title: Imatinib mesylate prevents cerebral vasospasm after subarachnoid hemorrhage via inhibiting tenascin-C expression in rats
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2012.01.005
– volume: 467
  start-page: 95
  issue: September (7311)
  year: 2010
  ident: 10.1016/j.phrs.2019.03.014_bib0165
  article-title: Gamma-secretase activating protein is a therapeutic target for Alzheimer’s disease
  publication-title: Nature
  doi: 10.1038/nature09325
– volume: 30
  start-page: 1109
  issue: 5
  year: 2012
  ident: 10.1016/j.phrs.2019.03.014_bib0300
  article-title: C-reactive protein increases BBB permeability: implications for obesity and neuroinflammation
  publication-title: Cell. Physiol. Biochem.
  doi: 10.1159/000343302
– volume: 6
  start-page: 131
  issue: Novemer (1)
  year: 2018
  ident: 10.1016/j.phrs.2019.03.014_bib0190
  article-title: In vivo induction of membrane damage by β-amyloid peptide oligomers
  publication-title: Acta Neuropathol. Commun.
  doi: 10.1186/s40478-018-0634-x
– volume: 21
  start-page: 3174
  issue: January (11)
  year: 2015
  ident: 10.1016/j.phrs.2019.03.014_bib0290
  article-title: Nuclear factor kappa B role in inflammation associated gastrointestinal malignancies
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v21.i11.3174
– volume: 81
  start-page: 1
  issue: April (1)
  year: 2002
  ident: 10.1016/j.phrs.2019.03.014_bib0230
  article-title: Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.2002.00855.x
– volume: 50
  start-page: 1447
  issue: May (5)
  year: 1988
  ident: 10.1016/j.phrs.2019.03.014_bib0035
  article-title: Protein tyrosine kinase activity and its endogenous substrates in rat brain: a subcellular and regional survey
  publication-title: J. Neurochem.
  doi: 10.1111/j.1471-4159.1988.tb03029.x
– volume: 134
  start-page: 585
  issue: October (4)
  year: 2017
  ident: 10.1016/j.phrs.2019.03.014_bib0315
  article-title: Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-017-1749-z
– volume: 23
  start-page: 542
  issue: March (3)
  year: 2016
  ident: 10.1016/j.phrs.2019.03.014_bib0070
  article-title: c-Abl–p38α signaling plays an important role in MPTP-induced neuronal death
  publication-title: Cell Death Differ.
  doi: 10.1038/cdd.2015.135
– volume: 15
  start-page: 571
  issue: 4
  year: 2016
  ident: 10.1016/j.phrs.2019.03.014_bib0010
  article-title: A safety evaluation of imatinib mesylate in the treatment of gastrointestinal stromal tumor
  publication-title: Expert Opin. Drug Saf.
  doi: 10.1517/14740338.2016.1152258
– volume: 61
  start-page: 294
  issue: March (3)
  year: 2015
  ident: 10.1016/j.phrs.2019.03.014_bib0040
  article-title: c-kit plays a critical role in induction of intravenous tolerance in experimental autoimmune encephalomyelitis
  publication-title: Immunol. Res.
  doi: 10.1007/s12026-015-8624-6
– volume: 3
  start-page: 701
  issue: 5
  year: 2007
  ident: 10.1016/j.phrs.2019.03.014_bib0320
  article-title: Management of intracerebral hemorrhage
  publication-title: Vasc. Health Risk Manag.
– volume: 114
  start-page: 1389
  issue: February (6)
  year: 2017
  ident: 10.1016/j.phrs.2019.03.014_bib0210
  article-title: Gleevec shifts APP processing from a β-cleavage to a nonamyloidogenic cleavage
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1620963114
– volume: 22
  start-page: 419
  issue: April (2)
  year: 2016
  ident: 10.1016/j.phrs.2019.03.014_bib0100
  article-title: Alzheimer’s disease
  publication-title: Continuum (Minneap Minn)
  doi: 10.1212/CON.0000000000000307
– volume: 122
  start-page: 289
  issue: January (2)
  year: 2008
  ident: 10.1016/j.phrs.2019.03.014_bib0420
  article-title: c-Abl activates p38 MAPK independently of its tyrosine kinase activity: Implications in cisplatin-based therapy
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.23063
– volume: 65
  start-page: 329
  year: 2012
  ident: 10.1016/j.phrs.2019.03.014_bib0090
  article-title: Alzheimer’s disease
  publication-title: Subcell. Biochem.
  doi: 10.1007/978-94-007-5416-4_14
– volume: 17
  start-page: 326
  issue: November (2)
  year: 2004
  ident: 10.1016/j.phrs.2019.03.014_bib0200
  article-title: Activation of the neuronal c-Abl tyrosine kinase by amyloid-beta-peptide and reactive oxygen species
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2004.06.007
– issue: November 20
  year: 2018
  ident: 10.1016/j.phrs.2019.03.014_bib0195
  article-title: Intracerebroventricular injection of resveratrol ameliorated Aβ-induced learning and cognitive decline in mice
  publication-title: Metab. Brain Dis.
– volume: 3
  start-page: 200
  issue: 7
  year: 2011
  ident: 10.1016/j.phrs.2019.03.014_bib0265
  article-title: Stroke: classification and diagnosis
  publication-title: Clin. Pharm.
– volume: 131
  start-page: 2425
  issue: September (Pt 9)
  year: 2008
  ident: 10.1016/j.phrs.2019.03.014_bib0150
  article-title: STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer’s beta-amyloid deposits
  publication-title: Brain
  doi: 10.1093/brain/awn125
– volume: 63
  start-page: 133
  issue: September (3)
  year: 2013
  ident: 10.1016/j.phrs.2019.03.014_bib0445
  article-title: p38(MAPK)/p53-Mediated Bax induction contributes to neurons degeneration in rotenone-induced cellular and rat models of Parkinson’s disease
  publication-title: Neurochem. Int.
  doi: 10.1016/j.neuint.2013.05.006
– volume: 66
  start-page: 553
  issue: September (4)
  year: 2017
  ident: 10.1016/j.phrs.2019.03.014_bib0105
  article-title: Lipopolysaccharide-induced memory impairment in rats: a model of Alzheimer’s disease
  publication-title: Physiol. Res.
  doi: 10.33549/physiolres.933480
– volume: 281
  start-page: 9824
  issue: April (14)
  year: 2006
  ident: 10.1016/j.phrs.2019.03.014_bib0460
  article-title: 6-Hydroxydopamine but not 1-methyl-4-phenylpyridinium abolishes alpha-synuclein anti-apoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M513903200
– volume: 6
  start-page: 39
  issue: February (1)
  year: 2015
  ident: 10.1016/j.phrs.2019.03.014_bib0270
  article-title: Longitudinal assessment of imatinib’s effect on the blood-brain barrier after ischemia/reperfusion injury with permeability MRI
  publication-title: Transl. Stroke Res.
  doi: 10.1007/s12975-014-0358-6
– volume: 29
  start-page: 37
  issue: August 5
  year: 2008
  ident: 10.1016/j.phrs.2019.03.014_bib0125
  article-title: Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation
  publication-title: J. Neuroinflammation
  doi: 10.1186/1742-2094-5-37
– volume: 17
  start-page: 13
  issue: November 1298
  year: 2009
  ident: 10.1016/j.phrs.2019.03.014_bib0295
  article-title: Modulation of blood-brain barrier permeability by neutrophils: in vitro and in vivo studies
  publication-title: Brain Res.
  doi: 10.1016/j.brainres.2009.08.076
SSID ssj0009410
Score 2.4267788
SecondaryResourceType review_article
Snippet [Display omitted] Imatinib is a tyrosine kinase inhibitor and is used as a first line drug in the treatment of Philadelphia-chromosome-positive chronic myeloid...
Imatinib is a tyrosine kinase inhibitor and is used as a first line drug in the treatment of Philadelphia-chromosome-positive chronic myeloid leukaemia and...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 86
SubjectTerms Alzheimer’s disease
Animals
Antineoplastic Agents - pharmacology
Antineoplastic Agents - therapeutic use
Brain
Humans
Imatinib
Imatinib Mesylate - pharmacology
Imatinib Mesylate - therapeutic use
Multiple sclerosis
Nervous System Diseases - drug therapy
Nervous System Diseases - metabolism
Parkinson disease
Protein Kinase Inhibitors - pharmacology
Protein Kinase Inhibitors - therapeutic use
Spinal Cord
Spinal cord injury
Stroke
Tyrosine kinase
Title Expanding spectrum of anticancer drug, imatinib, in the disorders affecting brain and spinal cord
URI https://dx.doi.org/10.1016/j.phrs.2019.03.014
https://www.ncbi.nlm.nih.gov/pubmed/30902661
https://www.proquest.com/docview/2196531526
Volume 143
WOSCitedRecordID wos000466827800009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals 2021
  customDbUrl:
  eissn: 1096-1186
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0009410
  issn: 1043-6618
  databaseCode: AIEXJ
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa6jQdeEHe2wWQk1Jc2qKmdOnmcUCeYSplQh_pm2Y6zdippadrR_Qb-NMeXpOGyaTzwEkWOnVj5PtvHPjeE3kgaS1hIu0GY9bKAhjQMBKxkQWj0iUqRSFsv1y8DNhzG43Fy1mj8KH1hrmYsz-PNJln8V6ihDMA2rrP_AHf1UiiAewAdrgA7XO8EfH-z8K4q1otyuf5qdf25ObQGhJetdLm243tqhNV8ahUy3tox9bE4i5awdh7mLdIkkbA6hmJhU2jZ_WpNpj3bRr-2iPv4QdU5c2XF_VHk06JWPCsmJjOIUzl9nq7W1XEPfHfieApvrmxATsXFhTU-gN-hi8l3sWzZmvWTC-MsVdoJ-skWtk9AijIU9l_Kyhmaktoc6579MfW7U4jLtzAGTBj20AWvdR6qv8bZHn7iJ-eDAR_1x6Pm4ltgUpAZVb3Px7KD9rosSmCK3Dv-0B-fbmM4Ux_cwnfR-2A5c8HfP3uTnHPTPsbKM6OH6IHfiOBjR6BHqKHzx6jpsbxu49HWMa9o4yauoXz9BImKZbhkGZ5neMsybFjWxiXH4C7HwDBcMQxXDMOWYdA2xY5h2DDsKTo_6Y_evQ98to5AwTqwClRKdZyITIc6lFHGUspIJkRP6iQyeR87Hd1LBDEbCsaYTLMeS4lSYZSBlBmrhDxDu_k81y8QlqTboZpQnamMSk2kUl2lKEs6UkmQ-PdRWP5brnwoe5NRZcZLm8VLbvDgBg_eIRzw2Eetqs3CBXK5tXZUQsa9KOpETA50u7Xd6xJfDvO0Ub6JXM_XUMmE7iQgLUPvnzvgq34QYxwNgvLBHVofovvbsfQS7QLA-hW6p65W02J5hHbYOD7yxP0Jb7DBNw
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Expanding+spectrum+of+anticancer+drug%2C+imatinib%2C+in+the+disorders+affecting+brain+and+spinal+cord&rft.jtitle=Pharmacological+research&rft.au=Kumar%2C+Manish&rft.au=Kulshrestha%2C+Ritu&rft.au=Singh%2C+Nirmal&rft.au=Jaggi%2C+Amteshwar+Singh&rft.date=2019-05-01&rft.issn=1096-1186&rft.eissn=1096-1186&rft.volume=143&rft.spage=86&rft_id=info:doi/10.1016%2Fj.phrs.2019.03.014&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1043-6618&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1043-6618&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1043-6618&client=summon